Retatrutide 10mg

Triple-receptor agonist research compound. GLP-1, GIP, and glucagon receptor activity. 39-amino acid synthetic peptide with C20 fatty diacid moiety.

Purity>99.6%

FormLyophilised powder

VerificationHPLC, Mass Spectrometry, Endotoxin

Storage2–8°C, protect from light

COA Download COA (PDF)

Retatrutide 10mg

$189

One-time

ORDERWed, 29 Apr

SHIPSWed, 29 Apr

ARRIVESMon, 4 May

Research Use Declaration

Before proceeding, you are required to confirm the following declarations. This confirmation forms a binding part of your purchase agreement with Pillar Research.

I confirm I am acquiring this compound solely for legitimate in vitro laboratory research purposes. Not for personal use, human consumption, animal consumption, therapeutic application, or clinical use.I acknowledge this product is not listed on the ARTG, has not been evaluated by the TGA, and is not approved for any therapeutic, diagnostic, or clinical application under the Therapeutic Goods Act 1989 (Cth).I am solely responsible for ensuring my acquisition and use complies with all applicable state, territory, and federal laws. Pillar Research provides no legal indemnity for non-compliant use.I have read and agree to Pillar Research's Terms and Conditions and Supply, Reshipment and Returns Policy.I confirm I am 18 years of age or older and have legal capacity to enter into a binding agreement.

Same-day dispatchTracked express deliveryAustralian stock